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Low-intensity pulsed ultrasound (LIPUS) is used for bone healing in orthopedics and dentistry. It has
been shown that LIPUS induces the secretion of extracellular adenosine triphosphate (ATP), a key
mediator of osteoblast response to mechanical stimuli. However, the detailed mechanism of
LIPUS-induced osteogenesis has been elusive. In this study, we investigated the role of the P2X7
receptor in LIPUS-induced osteogenesis. LIPUS induced the release of extracellular ATP, differentia-
tion of osteoblasts and osteogenesis via the P2X7 receptor, without affecting the activity of alkaline
phosphatase (ALPase). These results suggest that LIPUS-induced extracellular ATP promotes bone
formation via the osteoblast P2X7 receptor independently of ALPase.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction is calcium-dependent [6]. Extracellular ATP induces a variety ofBone formation and homeostasis is regulated by hormones,
cytokines, and external factors such as mechanical stimuli. In
adults, bone mass is maintained via bone remodeling induced by
mechanical stress, which is a one of the most important factors
affecting the amount and strength of the bone tissue [1].
Nucleotides released bymechanical stimulation or inﬂammation
act as autocrine/paracrine mediators of osteoclasts and osteoblasts
that participate in bone remodeling [2]. Adenosine triphosphate
(ATP) is a key regulator of osteoblast response tomechanical stimuli
[3,4]. Mechanosensitive ATP production is induced in various cell
types by such activities as pressure, stretch, and ﬂow shear, as well
as osmotic stress [2,5]. It has also been demonstrated that the
release of extracellular ATP by mechanically stimulated osteoblastsphysiological responses through activation of ATP-binding
purinergic (P2) receptors. These receptors, expressed on both osteo-
blasts and osteoclasts, can be divided into the P2Y family of G pro-
tein-coupled receptors and the P2X family of ligand-gated cation
channels [7]. MC3T3-E1 cells expressed P2X3, P2X4, P2X5 and
P2X7 [8]. In previous study, P2X4 is not mediated bone formation
by extracellular nucleotides [9]. In particular, the P2X7 receptor
has been shown to mediate pore formation in response to ﬂuid
shearing stress inmouse calvarial cells. P2X7/mice demonstrated
reduced periosteal bone formation in long bones and decreased
osteogenesis in response to mechanical loading; however, P2X7
deﬁciency did not affect the length of mouse long bones [10,11].
These reports indicate that the P2X7 receptormay play a critical role
in osteogenesis induced by mechanical stimuli.
Mechanical stimulation was applied by low-intensity pulsed
ultrasound (LIPUS) treatment accelerates healing and regeneration
of bone fractures and is used in clinics [12]. LIPUS exerts a variety
of direct and indirect effects such as acoustic radiation force,
S. Manaka et al. / FEBS Letters 589 (2015) 310–318 311acoustic streaming, and propagation of surface waves, thus
promoting ﬂuid ﬂow-induced circulation and redistribution of
nutrients, oxygen, and signaling molecules. In addition, the trans-
formation of acoustic wave energy into heat can be ignored, and
cavitation at the pressure levels delivered by LIPUS normally does
not occur. Previous studies have reported that LIPUS promotes
osteoblast differentiation and osteogenesis in vitro [13–16]. Thus,
LIPUS induces osteoblast proliferation and expression of receptor
activator of nuclear factor-kappa B ligand (RANKL) via ATP release
in SaOS-2 cells [17], suggesting that the secretion of extracellular
ATP may underlie the osteogenic effects of LIPUS. However, the
involvement of the ATP-gated P2X7 receptor in LIPUS-induced
bone regeneration is poorly understood. In this study, our main
purpose was to elucidate the involvement of the P2X7 receptor
in the LIPUS-induced osteogenic effects in calvarial osteoblast-like
MC3T3-E1 cells. For this, we assessed the expression of transcrip-
tion factors RUNX2 and Osterix, which regulate osteoblast differen-
tiation, and measured accumulation of inorganic phosphate and
calcium in the extracellular matrix, and the expression of bone
ECM proteins.
2. Materials and methods
2.1. Cell culture
The mouse calvarial cell line MC3T3-E1, obtained from Riken
Bio Resource Center (Tsukuba, Japan), was used as a model for
osteoblasts. Cells were maintained in a-minimal essential medium
(a-MEM; Gibco BRL, Rockville, MD, USA) containing 10% (v/v) heat-
inactivated fetal bovine serum (HyClone Laboratories, Logan, UT,
USA) and 1% (v/v) penicillin–streptomycin solution (Sigma–
Aldrich, St. Louis, MO, USA) at 37 C in a humidiﬁed atmosphere
of 95% air and 5% CO2. The medium was changed every 3 days.
2.2. Application of low-intensity pulsed ultrasound (LIPUS)
Cells were seeded on 6-well culture plates (IWAKI, Tokyo,
Japan) at the density of 2  104 cells/cm2 for 24 h prior to stimula-
tion with LIPUS (1.5 MHz, pulsed-wave mode intensity of 30 mW/
cm2) for a maximum of 24 h [13]. LIPUS was applied using a ster-
ilized transducer (OSTEOTRON D2: Ito Co. Ltd., Tokyo, Japan) placed
on the surface of culture medium so that the distance between the
transducer and the cells was approximately 3–4 mm. Control cells
were seeded at the same density but were not stimulated with
LIPUS.Table 1
PCR primers used in the experiments.
Target Primers
RUNX2 50-CACTCTGGCTTTGGG
50-GCAGTTCCCAAGCAT
Osterix 50-GGTAGGCGTCCCCCA
50-AGACGGGACAGCCA
P2X7 50-TGCAGCTGGAACGA
50-CGCTGGTACAGCTTA
Type I collagen 50-TGGGCGCGGCTGGT
50-ACCCTGCTACGACAA
Bone sialoprotein 50-AATTCTGACCCTCGT
50-GAGCCTCGTGGCGA
Osteopontin 50-TACGACCATGAGATT
50-TATAGGATCTGGGTG
Osteocalcin 50-AAGCAGGAGGGCAA
50-ACCCTGCTACGACAA
GAPDH 50-AAATGGTGAAGGTC
50-TGAAGGGGTCGTTG
GAPDH, glyceraldehyde-3-phosphate dehydrogenase.2.3. Luciferin–luciferase bioluminescence assay
Cells were seeded at a density of 2  104 cells/cm2 onto 6-well
plates 24 h prior to stimulation. The medium was then replaced
with 3 ml of fresh culture medium containing ARL67156 (Sigma–
Aldrich), an ATPase inhibitor, and the cells were incubated for
30 min and then stimulated with LIPUS for a maximum of
30 min. The concentration of extracellular ATP was determined
using the Kinsiro ATP Luminescence kit (Toyo Ink SC Holdings
Co. Tokyo, Japan). For this, 50 ll of the luciferin–luciferase assay
mix dissolved in culture medium was added to a 50 ll sample
and bioluminescence was immediately measured using a Lumi-
nescencer Octa luminometer (ATTO Co. LTD., Tokyo, Japan). A stan-
dard curve was generated for each luciferase assay using serial
dilutions of an ATP standard.
2.4. Real-time polymerase chain reaction
Cells were seeded on 6-well plates and cultured for up to
14 days. Total RNA was isolated on days 3, 7, and 14 of culture
using the RNeasy Mini Kit (QIAGEN, Valencia, CA, USA); RNA con-
centration was measured by NanoDrop 1000 (ND-1000; Thermo
Fisher Scientiﬁc, Wilmington, DE, USA). Complementary DNA
(cDNA) was synthesized from 0.5 lg of DNase-treated total RNA
using the PrimeScript RT reagent kit (Takara Bio, Shiga, Japan),
and the resultant cDNA was analyzed by real-time PCR using the
SYBR Green kit (Takara Bio). The reactions were performed in a
total volume of 25 ll containing 12.5 ll of SYBR premixed Ex
Taq, 0.5 ll (20 mM) of each primer (Table 1), 9.5 ll of dH2O, and
2 ll (0.5 lg) of cDNA. The PCR assays were performed in a Smart
Cycler II instrument (Cepheid, Sunnyvale, CA, USA) and analyzed
using Smart Cycler software. The cycling conditions included 35
cycles at 95 C for 5 s and 60 C for 20 s. All real-time PCR experi-
ments were performed in triplicate, and the speciﬁcity of the
ampliﬁed products was veriﬁed by melting curve analysis. The cal-
culated values of target gene expression were normalized to that of
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) used as an
internal control.
2.5. SDS–polyacrylamide gel electrophoresis and Western blotting
After LIPUS stimulation, cells were cultured in serum-free med-
ium for additional 24 h, and then collected and subjected to
sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS–
PAGE) using 10% polyacrylamide gels (8.3 cm  6.5 cm  0.75 mm)GenBank Acc.
AAGAG-30
TTCAT-30
NM_001145920.1
TGGTTT-30
ACCCTAG-30
NM_130458.3
TGTCTTG-30
TCGCTCA-30
NM_011027.2
ATGAGTTC-30
CGTGCC-30
NM_007743.2
AGCCTTCATA-30
CACTTA-30
NM_008318.3
GGCAGTGA-30
CAGGCTGTAA-30
NM_009263.3
TAAGGT-30
CGTGCC-30
NM_007541.2
GGTGTG-30
ATGG-30
NM_008084.2
Fig. 1. Time course of ATP release by LIPUS. MC3T3-E1 cells were cultured with the
ATPase inhibitor ARL67156 (50 lM) for 30 min before LIPUS stimulation for 0, 1, 5,
10, 15, 20, or 30 min. ATP release was quantiﬁed by the luciferin–luciferase
bioluminescence assay. Data are expressed as the mean ± standard error (S.E.M.) of
three independent experiments performed in triplicate; ⁄P < 0.05, LIPUS vs. 0 min
(control).
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taining 10 ng of extracellular protein were dissolved in 10 ll of
sample buffer containing 1% SDS, 2 M urea, 15 mg/ml dithiothrei-
tol, and bromophenol blue, and then heated at 95 C for 5 min
before loading onto the gel. Proteins were separated at 150 V for
60 min and transferred onto a PVDF membrane using a semi-dry
electrotransfer unit and transfer buffer containing 39 mM glycine,
48 mM Tris, 0.0375% SDS, and 20% (v/v) methanol at the constant
current of 0.8 mA/cm2 for 60–90 min. The membrane was then
treated with 25% (v/v) blocking reagent in Tris-buffered saline
(TBS) (10 mM Tris, 145 mM NaCl, pH 7.4) for 18 h at 4 C, washed
in Tween 20-containing TBS (TBS-Tween), and incubated with rab-
bit polyclonal IgG antibodies against RUNX2, Osterix, P2X7 and b-
tubulin (all from Santa Cruz Biotechnology, Santa Cruz, CA, USA)
diluted 1:200 in 10% (v/v) blocking reagent in water, for 90 min
at room temperature; b-tubulin was used as an internal standard.
The membranes were washed in TBS-Tween and incubated with
biotin-conjugated secondary antibodies diluted 1:10,000 in 10%
blocking agent in distilled water for 60 min at room temperature.
The membranes were washed in TBS-Tween and phosphate-buf-
fered saline (PBS; Nissui Pharmaceutical Co. Ltd., Tokyo, Japan)
and incubated with horseradish peroxidase-conjugated streptavi-
din in PBS for 30 min at room temperature. Immunoreactive pro-
teins were visualized using a chemiluminescence kit (Amersham
Life Sciences, Buckinghamshire, UK) and autoradiography (X-ray)
ﬁlms (Eastman Kodak, New Haven, CT, USA). Pre-stained molecular
weight standards were run on the same gel. The band intensity was
quantiﬁed using digital image analysis software (GS-800
Calibrated Densitometer and Quantity One Version 4.2.1, Bio-Rad,
Hercules, CA, USA).
2.6. Enzyme-linked immunosorbent assay (ELISA)
After LIPUS stimulation, cells were cultured in serum-free
medium for additional 24 h. The concentrations of type I collagen,
bone sialoprotein, osteopontin, and osteocalcin in the culture med-
ium at 3, 7, and 14 days were determined using commercially
available ELISA kits (R&D Systems, Cusabio Biotech Co., Uscn Life
Science Inc. and Biomedical Technologies Inc.) according to the
manufacturers’ instructions.
2.7. Alkaline phosphatase activity assay
Cells were ﬁxed with 4% neutral buffered formalin overnight at
4 C. Alkaline phosphatase (ALPase) activity was assessed by treat-
ment with a mixture of 0.25 mM naphthol AS-MX phosphate
(Sigma–Aldrich) and 1.25 mM Fast Red B salt (Sigma–Aldrich) in
0.1 M Tris–HCl, pH 8.0, for 1 h in the dark. The cells were observed
under a phase-contrast microscope with a Plan 10 DL objective
(Nikon, Tokyo, Japan). The planar area of ALP positive staining
was quantiﬁed using NIS-Elements D 3.2 software (Nikon).
2.8. Phosphate assay and mineral content in ECM
After LIPUS stimulation, the cells were cultured in serum-free
medium for an additional 24 h. The concentration of inorganic
phosphate (Pi) in the culture medium at 3, 7, and 14 days was
determined using the Malachite Green Phosphate Assay Kit (BioAs-
say Systems, Hayward, CA, USA) according to the manufacturer’s
instructions.
To quantify mineral content, the cells were cultured in the pres-
ence of 50 lg/ml ascorbic acid and 10 mM b-glycerophosphate [18]
for 14 days; the medium was changed every 2–3 days. At the end
of cultivation, 300 ll of 0.5 M HCl was added to each well, and
the cells were left overnight for decalciﬁcation of mineralized
nodules. Calcium content was determined quantitatively usingthe Calcium E-Test kit (Wako Fine Chemicals, Osaka, Japan) accord-
ing to the manufacturer’s instructions. Protein concentration was
measured using the Bio-Rad protein assay (Bio-Rad Laboratories)
after HCl evaporation.
2.9. Cell viability
After LIPUS stimulation, cells were stained with 0.4 w/v% trypan
blue solution to determine cell viability. Viable (trypan blue-nega-
tive) cells were counted using a DIAPHOT phase-contrast
microscope.
2.10. Knockdown of P2X7 by short hairpin RNA in MC3T3-E1 cells
To obtain stable P2X7-deﬁcient clones, the cells were transfec-
ted with Lentiviral Particles containing the puromycin resistance
gene for antibiotic selection and P2X7 short hairpin RNA (shRNA)
or non-target (scrambled) control shRNA (Santa Cruz Biotechnol-
ogy, Santa Cruz, CA, USA) and cultured in the presence of 5 lg/ml
puromycin (Enzo Life Sciences Inc., Farmingdale, NY, USA). After
stable clones had been selected, real-time PCR and Western blot-
ting were performed to conﬁrm P2X7 knockdown.
2.11. Statistical analysis
All data present the results of three independent experiments
performed in triplicate or quintuplicate. Each value represents
the mean ± standard error (S.E.M.). The signiﬁcance of differences
was determined using Student’s t-test, one-way analysis of vari-
ance followed by Tukey’s multiple comparisons test or two-way
analysis of variance by Bonferroni’s multiple comparisons test.
Differences were considered statistically signiﬁcant at P < 0.05.3. Results
3.1. LIPUS effects on the release of extracellular ATP
We examined the effect of LIPUS on the release of extracellular
ATP by MC3T3-E1 osteoblasts. LIPUS signiﬁcantly stimulated
extracellular ATP release at 1 and 3 min compared to the untreated
control cells, which did not secrete ATP (Fig. 1).
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LIPUS gradually increased mRNA expression of RUNX2 in oste-
oblasts through day 3 of culture; the expression subsequently
decreased by day 5. In osteoblasts stimulated by LIPUS for 5, 10,
20, and 30 min, RUNX2 expression was signiﬁcantly increased, by
1.7-, 1.7-, 1.8-, and 2.8-fold, respectively, at day 3 of culture com-
pared to the untreated cells (Fig. 2a).
LIPUS also signiﬁcantly increased Osterix mRNA in osteoblasts,
especially at day 1 of culture. Osterix expression in osteoblasts
stimulated by LIPUS for 5, 10, 20, and 30 min gradually increased,
by 1.6-, 1.9-, 2.2-, and 2.9-fold, respectively, compared to the
untreated control, at days 1, 3, and/or 5 of culture (Fig. 2b).
A similar effect was observed on the expression of the P2X7
receptor in osteoblasts, where LIPUS stimulation for 5, 10, 20,
and 30 min upregulated P2X7 by 2.1-, 2.0-, 2.5- and 4.1-fold,
respectively, at day 3 compared to control (Fig. 2c).
These results indicate that LIPUS upregulated mRNA expression
of RUNX2, Osterix, and P2X7 in a time-dependent manner and the
treatment for 30-min had the maximum effect.
3.3. Effects of P2X7 receptor antagonist A438079 on RUNX2 and
Osterix expression
We investigated the effect of P2X7 on the LIPUS-induced
expression of RUNX2 and Osterix by treating LIPUS-stimulated
cells with A438079, a selective antagonist of the P2X7 receptor
[19,20]. We chose to use the 30 min/day stimulation with LIPUS
because it had the strongest effect compared to other time points
according to Fig. 2. LIPUS increased mRNA levels of RUNX2 and
Osterix in osteoblasts by day 3 of culture (by 1.7- and 1.9-fold,
respectively), but the effect gradually decreased by day 14Fig. 2. Effects of LIPUS on the expression of RUNX2, Osterix, and the P2X7 receptor. M
stimulation (control) and mRNA expression of RUNX2 (a), Osterix (b), and P2X7 (c) was d
the mean ± S.E.M. of three independent experiments performed in triplicate; ⁄P < 0.05, ⁄(Fig. 3a and b). However, the LIPUS-elicited upregulation of mRNA
and protein expression of RUNX2 and Osterix on day 3 was inhib-
ited by A438079 (Fig. 3c).
3.4. Effects of LIPUS and A438079 on the expression of ECM proteins
To clarify the role of LIPUS-induced ATP on osteogenesis, we
determined the expression of ECM proteins at the mRNA and pro-
tein levels in MC3T3-E1 cells stimulated with LIPUS and treated
with A438079.
In LIPUS-stimulated osteoblasts, mRNA expression of type I
collagen was upregulated by 2.0-fold at day 3, and that of bone
sialoprotein, osteopontin, and osteocalcin was increased by 1.4-,
3.75-, and 2.1-fold, respectively, at day 14 of culture, compared
to the untreated control (Fig. 4). The increase in protein expression
was consistent with that in mRNA (Fig. 5). However, P2X7 antago-
nist A438079 blocked LIPUS stimulatory effect on the expression of
these ECM components both at mRNA and protein levels (Figs. 4
and 5).
3.5. Effects of LIPUS and A4348079 on ALPase activity, cell viability,
phosphate concentration, and calcium content in the ECM
To investigate the role of LIPUS-induced ATP in the formation of
mineralized nodules, we determined ALPase activity and calcium
content in the ECM produced by MC3T3-E1 cells after stimulation
with LIPUS and treatment with A438079. ALPase activity and cell
viability were not affected by LIPUS (Fig. 6a–d). LIPUS signiﬁcantly
increased phosphate concentration (by 1.3-fold) and calcium con-
tent (by 1.8-fold) in the ECM on 14 day of culture compared to the
untreated cells (Fig. 6e and f). However, A438079 reduced the
stimulatory effects of LIPUS on the deposition of phosphate and
calcium in the ECM.C3T3-E1 cells were stimulated with LIPUS (5, 10, 20, and 30 min) or left without
etermined on days 1, 3 and 5 of culture using real-time PCR. Data are expressed as
⁄P < 0.01, LIPUS vs. control.
Fig. 3. Effects of A438079 on the expression of RUNX2, Osterix. Cells were stimulated or not with LIPUS in the presence or absence of A438079 (10 lM) and mRNA expression
of RUNX2 (a) and Osterix (b) was determined by real-time PCR at day 3 of culture. Data are expressed as the mean ± S.E.M. of three independent experiments performed in
triplicate; ⁄P < 0.05, ⁄⁄P < 0.01, LIPUS vs. control; +P < 0.05, ++P < 0.01, LIPUS vs. LIPUS + A438079. The protein expression of RUNX2 and Osterix was determined by Western
blotting on day 3 of culture (c).
Fig. 4. Effects of LIPUS and A438079 on the mRNA expression of ECM proteins. MC3T3-E1 cells stimulated or not with LIPUS for 30 min per day during 14 days in the presence
or absence of A438079 (10 lM) and mRNA expression of type I collagen (a), bone sialoprotein (b), osteopontin (c), and osteocalcin (d) was determined by real-time PCR on
days 3, 7, and 14 of culture. Data are expressed as the mean ± S.E.M. of three independent experiments performed in triplicate; ⁄P < 0.05, ⁄⁄P < 0.01, LIPUS stimulation vs.
control, +P < 0.05, ++P < 0.01, LIPUS vs. LIPUS + A438079.
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Fig. 5. Effects of LIPUS and A438079 on the protein expression of ECM proteins. Protein expression of type I collagen (a), bone sialoprotein (b), osteopontin (c), and osteocalcin
(d) was determined by ELISA on days 3, 7, and 14 of culture. Data are expressed as the mean ± S.E.M. of three independent experiments performed in triplicate; ⁄P < 0.05,
⁄⁄P < 0.01, LIPUS stimulation vs. control, +P < 0.05, ++P < 0.01, LIPUS vs. LIPUS + A438079.
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To clarify the role of LIPUS-induced ATP on osteogenesis, we
determined the expression of the ECM proteins at the mRNA level
in the P2X7-deﬁcient cells stimulated with LIPUS. For this, MC3T3-
E1 osteoblasts were transfected with P2X7-speciﬁc shRNA (sh
P2X7), which decreased the expression of P2X7 mRNA by more
than 2-fold compared to the cells transfected with scrambled
shRNA (sh control) (Fig. 7a). Consistently, sh P2X7 also reduced
P2X7 protein expression by 2-fold compared to sh control
(Fig. 7b and c).
In the control shRNA-transfected cells stimulated with LIPUS,
mRNA expression of type I collagen was increased by 1.4-fold on
day 3, and that of bone sialoprotein, osteopontin, and osteocalcin
was induced by 1.3-, 2.1-, and 2.0-fold, respectively, on day 14 of
culture, compared to the untreated cells (Fig. 8a–d). However, this
stimulatory effect was blocked in the sh P2X7-transfected cells
(Fig. 8a–d).
4. Discussion
LIPUS is a medical technology based on the application of
mechanical stress, which has been proven to have clinical effects
on bone fracture healing [21]. A previous in vitro study has shown
that LIPUS induces osteogenesis and suppresses adipogenesis in
mouse bone marrow cells [22].
Mechanical stress such as pressure, stretch, and ﬂuid shear, as
well as osmotic stress induce the release of extracellular ATP in
various cell types [2,5], including osteoblasts where extracellular
ATP release is stimulated via both constitutive and inductive
mechanisms [23]. It has been demonstrated that the secretion of
extracellular ATP promotes osteogenesis in rat calvarial cells
in vitro [24].The P2X7 receptor is a non-selective cation channel permeable
to Na+, K+, and Ca2+. ATP and 20(3)-O-(4-benzoylbenzoyl) ATP
(BzATP) are agonists of P2X7 that induce the opening of P2X7
channels causing the elevation in intracellular calcium and depo-
larization of the plasma membrane [25]. Osteoblasts express func-
tional P2X7 receptors both in situ and in vitro [26]. In vivo studies
have shown that P2X7/ mice have reduced osteogenesis in
load-bearing bones, suggesting the role of P2X7 in the skeletal
bone response to mechanical stress [10,11].
In this study, we tested the hypothesis that LIPUS promotes
osteogenesis through the ATP-P2X7 pathway by examining the
secretion of extracellular ATP after LIPUS stimulation of osteo-
blast-like MC3T3-E1 cells. Previous ﬁndings indicate that a P2X7
receptor agonist BzATP promotes the production of lysophospha-
tidic acid (LPA) which is involved in P2X7-induced osteogenesis
via activation of phospholipases D and A2, and induction of the
cyclooxygenase (COX) pathway, acting in concert with LPA recep-
tor signaling in osteoblasts [26]. COX enzymes mediate the conver-
sion of arachidonic acid into prostaglandin (PG) E2 [26], shown to
be induced by ATP release in response to mechanical stimulation
in MC3T3-E1 cells [2]. We observed that LIPUS induced COX-2
expression via P2X7 (data not shown); therefore, the released
ATP could activate P2X7 and upregulate LPA or PGE2 via COX-2
activity. We hypothesized that LIPUS-induced ATP may stimulate
these physiological responses and promote osteogenesis. Our
results indicate that LIPUS stimulation for 1 and 3 min induced
extracellular ATP release, which was reversed after 10 min. The
half-life of osteoblast-released extracellular ATP has been reported
to be 10 min [27]; however, the downstream events caused by
LIPUS-induced ATP are likely to last longer [7]. Indeed, we showed
that LIPUS stimulation for 30 min had maximum effect on the
increase of RUNX2 and Osterix mRNA, the key transcriptional reg-
ulators of osteoblast differentiation, as evidenced by the study of
Fig. 6. Effects of LIPUS and A438079 on ALPase activity, extracellular phosphate concentration, cell viability, and calcium content in the ECM. MC3T3-E1 cells stimulated or
not with LIPUS for 30 min per day during 14 days in the presence or absence of A438079 (10 lM) were ﬁxed with 4% formalin and treated with 0.25 mM naphthol AS-MX
phosphate and 1.25 mM Fast Red B salt to detect ALP activity. Cells were observed under a phase-contrast microscope (original magniﬁcation,  100) (a); histograms show
the percentage of ALPase activity under each condition (b). To determine cell viability, cells were stained with 0.4 w/v% trypan blue on days 1 and 14 of culture and observed
under a phase-contrast microscope (original magniﬁcation,  100) (c); histograms show the percentage of viable cells under each condition (d). Inorganic phosphate
concentration was quantiﬁed using the Malachite Green Assay Kit (c). Calcium content in the ECM was determined using the Calcium E-Test kit (d). Data are expressed as the
mean ± S.E.M. of three independent experiments performed in triplicate; ⁄P < 0.05, ⁄⁄P < 0.01, LIPUS stimulation vs. control, +P < 0.05, ++P < 0.01, LIPUS vs. LIPUS + A438079.
316 S. Manaka et al. / FEBS Letters 589 (2015) 310–318mice deﬁcient in RUNX2 and Osterix expression [28]. A438079, a
selective antagonist of the P2X7 receptor [19,20], blocked the
expression of RUNX2 and Osterix induced by LIPUS. In rats,
A438079 inhibited BzATP-mediated changes in intracellular
calcium concentration through P2X7 but not other P2 receptors,
conﬁrming A438079 speciﬁcity to P2X7 [19]. Moreover, Nakashi-
ma et al. [28] have reported that an osteocalcin-encoding gene reg-
ulated by Osterix, is downregulated in P2X7/ calvarial cells.
Type I collagen is one of the major protein constituents of the
bone ECM; it also functions as a scaffold for the nucleation of
hydroxyapatite crystals during the calciﬁcation process. Non-col-
lagenous matrix proteins such as bone sialoprotein, osteopontin,
and osteocalcin have important roles in the organization of the col-
lagen matrix and in the regulation of the formation and growth of
hydroxyapatite crystals [29]. Bone sialoprotein, similar to type I
collagen, serves as a nucleation center for the hydroxyapatite for-
mation in the bone [30]. Osteocalcin is the most abundant non-col-
lagenous bone matrix protein [31]; this small c-carboxyglutamate
protein is selectively expressed by osteoblasts and binds calcium
ions [32]. The functions of osteopontin in the bone formation andremodeling are diverse and directly related to its fundamental
roles in host defense and tissue repair [33].
ALPase hydrolyzes ester bonds in organic phosphate com-
pounds under alkaline conditions and plays an important role in
bone calciﬁcation [34]. Previous our study showed that a one of
the mechanical stimuli tension force affects ALPase activity in min-
eralization of osteoblasts [35]. In this study, we observed that
LIPUS enhanced ECM protein expression and increased phosphate
concentration and calcium content in the ECM and that A438079
blocked these LIPUS effects. Furthermore, P2X7 gene silencing
inhibited LIPUS stimulatory effects on the expression of the genes
encoding ECM proteins. However, LIPUS did not affect ALPase
activity important in bone mineralization. LIPUS and tension force
are different kinds of mechanical stimuli. Thus, it may cause differ-
ent process of mineralized nodule formation induced by these
stimulations.
Extracellular ATP concentrations depend on the balance
between ATP release and its degradation by ectonucleotidases.
The ATP-related increase in phosphate levels and mineral
deposition in MC3T3-E1 cells observed here and in a previous
Fig. 7. Effects of P2X7-speciﬁc shRNA on P2X7 gene silencing in MC3T3-E1 cells. MC3T3-E1 cells were transfected with Lentiviral Particles containing P2X7-speciﬁc shRNA
(shP2X7) or control scrambled shRNA (sh control). Total RNA and protein was puriﬁed from conﬂuent cells, and the expression of P2X7 mRNA and protein was determined by
real-time PCR (a) and Western blotting (b); histograms show the intensity of Western blotting bands under each condition (c). Data are expressed as the mean ± S.E.M. of
three independent experiments performed in triplicate; ⁄P < 0.05, ⁄⁄P < 0.01, sh P2X7 vs.sh control.
Fig. 8. Effects of LIPUS on mRNA expression of ECM proteins in P2X7-deﬁcient osteoblasts. MC3T3-E1 cells transfected with P2X7 shRNA (sh P2X7) or scrambled shRNA (sh
control) were stimulated or not with LIPUS for 30 min per day during 14 days and mRNA expression of type I collagen (a), bone sialoprotein (b), osteopontin (c), and
osteocalcin (d) was determined by real-time PCR on days 3, 7, and 14 of culture. Data are expressed as the mean ± S.E.M. of three independent experiments performed in
triplicate; ⁄P < 0.05, ⁄⁄P < 0.01, sh control + LIPUS vs. sh control, +P < 0.05, ++P < 0.01, sh P2X7 + LIPUS vs. sh control + LIPUS.
S. Manaka et al. / FEBS Letters 589 (2015) 310–318 317study, suggests that ATP-hydrolyzing enzymes such as transgluta-
minase 2 (TG2), contribute to the elevation of phosphate
concentration. Indeed, ATPases have been shown to mediatemineralization without ALPase activity [36]; TG2 acts as ATPase
in a calcium-dependent environment [37]. We observed that
A438079 blocked phosphate deposition induced by LIPUS,
318 S. Manaka et al. / FEBS Letters 589 (2015) 310–318probably because its inhibition of the P2X7 receptor results in cal-
cium decrease in the environment.
In summary, LIPUS induced the release of extracellular ATP,
expression of osteogenesis-related transcription factors, and
deposition of ECM proteins through the P2X7 receptor in osteo-
blast-like cells. Furthermore, LIPUS increased inorganic phosphate
and mineral accumulation in the ECM; however, the activity of
ALPase was not affected. Overall, our results suggest that in osteo-
blasts, LIPUS-induced ATP promotes bone formation via the P2X7
receptor independently of ALPase activity.
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